Amdocs (NASDAQ:DOX) Rating Lowered to Buy at StockNews.com

Amdocs (NASDAQ:DOX) was downgraded by equities researchers at StockNews.com from a “strong-buy” rating to a “buy” rating in a note issued to investors on Tuesday.

Several other analysts have also recently commented on DOX. Barclays decreased their price target on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating for the company in a report on Thursday, November 14th. Oppenheimer lifted their price objective on Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a research report on Wednesday, November 13th. Finally, Stifel Nicolaus started coverage on Amdocs in a research report on Wednesday, October 2nd. They issued a “buy” rating and a $100.00 target price on the stock. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $101.20.

Amdocs Stock Up 0.7 %

Shares of Amdocs stock opened at $84.26 on Tuesday. The company has a current ratio of 1.20, a quick ratio of 1.24 and a debt-to-equity ratio of 0.21. Amdocs has a 1 year low of $74.41 and a 1 year high of $94.04. The stock has a 50-day moving average price of $86.33 and a 200 day moving average price of $85.78. The company has a market cap of $9.51 billion, a P/E ratio of 19.87, a P/E/G ratio of 1.46 and a beta of 0.71.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the stock. Private Trust Co. NA raised its position in shares of Amdocs by 62.9% in the third quarter. Private Trust Co. NA now owns 303 shares of the technology company’s stock valued at $27,000 after purchasing an additional 117 shares during the period. Brooklyn Investment Group acquired a new position in Amdocs in the 3rd quarter valued at $28,000. Catalyst Capital Advisors LLC bought a new position in Amdocs in the 3rd quarter worth $55,000. GAMMA Investing LLC lifted its position in Amdocs by 115.1% during the 3rd quarter. GAMMA Investing LLC now owns 800 shares of the technology company’s stock worth $70,000 after acquiring an additional 428 shares during the last quarter. Finally, Meeder Asset Management Inc. bought a new stake in Amdocs during the third quarter valued at about $77,000. 92.02% of the stock is owned by institutional investors.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.